A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population

1. British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med 2013;23:3–35. British Committee for Standards in Haematology Milkins C Berryman J Cantwell C Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology . Transfus Med 2013 ; 23 : 3 – 35 . 10.1111/j.1365-3148.2012.01199.x23216974 Search in Google Scholar

2. Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8. Boral LI Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures . Transfusion 1977 ; 17 : 163 – 8 . 10.1046/j.1537-2995.1977.17277151923.x403642 Search in Google Scholar

3. Technical manual, 20th ed. Bethesda, MD: AABB, 2020. Technical manual , 20th ed . Bethesda, MD : AABB , 2020 . Search in Google Scholar

4. Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137–41. Oberman HA Barnes BA Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion . Transfusion 1978 ; 18 : 137 – 41 . 10.1046/j.1537-2995.1978.18278160574.x417431 Search in Google Scholar

5. Cordle DG, Strauss RG, Snyder EL, Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol 1990;94:428–31. Cordle DG Strauss RG Snyder EL Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing . Am J Clin Pathol 1990 ; 94 : 428 – 31 . 10.1093/ajcp/94.4.4282220670 Search in Google Scholar

6. Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579–84. Heddle NM O’Hoski P Singer J McBride JA Ali MA Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing . Br J Haematol 1992 ; 81 : 579 – 84 . 10.1111/j.1365-2141.1992.tb02995.x1390245 Search in Google Scholar

7. The Drug and Cosmetics Act, 1940, and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India; 268–288. Available from http://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf. Accessed 22 January 2022. The Drug and Cosmetics Act, 1940, and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005 . Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India ; 268 – 288 . Available from http://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf . Accessed 22 January 2022 . Search in Google Scholar

8. National Standards for Blood Centres and Blood Transfusion Services, 2nd ed., Ministry of Health & Family Welfare, Government of India, 2022. National Standards for Blood Centres and Blood Transfusion Services , 2nd ed ., Ministry of Health & Family Welfare, Government of India , 2022 . Search in Google Scholar

9. Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. Lancet Haematol 2019;6:e606–15. Roberts N James S Delaney M Fitzmaurice C. The global need and availability of blood products: a modelling study . Lancet Haematol 2019 ; 6 : e606 – 15 . 10.1016/S2352-3026(19)30200-531631023 Search in Google Scholar

10. Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Asian J Transfus Sci 2017;11:40–4. Tiwari AK Aggarwal G Dara RC Arora D Gupta GK Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients . Asian J Transfus Sci 2017 ; 11 : 40 – 4 . 10.4103/0973-6247.200774534527928316439 Search in Google Scholar

11. Pathak S, Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India. Asian J Transfus Sci 2011;5:153–6. Pathak S Chandrashekhar M Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India . Asian J Transfus Sci 2011 ; 5 : 153 – 6 . 10.4103/0973-6247.83242315924621897595 Search in Google Scholar

12. Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014;50:271–3. Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014 ; 50 : 271 – 3 . 10.1016/j.transci.2014.01.00324472664 Search in Google Scholar

13. Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci 2011;5:157–9. Chaudhary R Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting . Asian J Transfus Sci 2011 ; 5 : 157 – 9 . 10.4103/0973-6247.83243315924721897596 Search in Google Scholar

14. Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8. Boral LI Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures . Transfusion 1977 ; 17 : 163 – 8 . 10.1046/j.1537-2995.1977.17277151923.x403642 Search in Google Scholar

15. Bruggeman CW, Nagelkerke SQ, Lau W, et al. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. Blood Adv 2020;4:3416–26. Bruggeman CW Nagelkerke SQ Lau W Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products . Blood Adv 2020 ; 4 : 3416 – 26 . 10.1182/bloodadvances.2020002253739113432722782 Search in Google Scholar

16. Bachofner A, Rüfli T, Holbro A, et al. The remarkable journey of a low-frequency alloantibody. Transfus Med Hemother 2019;46:384–5. Bachofner A Rüfli T Holbro A The remarkable journey of a low-frequency alloantibody . Transfus Med Hemother 2019 ; 46 : 384 – 5 . 10.1159/000490503687658431832065 Search in Google Scholar

17. Mintz PD, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test. Transfusion 1982;22:107–10. Mintz PD Haines AL Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test . Transfusion 1982 ; 22 : 107 – 10 . 10.1046/j.1537-2995.1982.22282177114.x7071913 Search in Google Scholar

18. Garratty G. Abbreviated pretransfusion testing. Transfusion 1986;26:217–9. Garratty G. Abbreviated pretransfusion testing . Transfusion 1986 ; 26 : 217 – 9 . 10.1046/j.1537-2995.1986.26386209371.x3085295 Search in Google Scholar

19. Oberman HA, Barnes BA, Steiner EA. Role of the crossmatch in testing for serologic incompatibility. Transfusion 1982;22: 12–6. Oberman HA Barnes BA Steiner EA. Role of the crossmatch in testing for serologic incompatibility . Transfusion 1982 ; 22 : 12 – 6 . 10.1046/j.1537-2995.1982.22182154207.x6801826 Search in Google Scholar

20. Pandey P, Setya D, Srivastava R, Singh MK. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing. Immunohematology 2020;36:19–28. Pandey P Setya D Srivastava R Singh MK. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing . Immunohematology 2020 ; 36 : 19 – 28 . 10.21307/immunohematology-2020-038 Search in Google Scholar

21. Datta SS, Mukherjee S, Talukder B, Bhattacharya P, Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India. Adv Hematol 2015;2015:610931. Datta SS Mukherjee S Talukder B Bhattacharya P Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India . Adv Hematol 2015 ; 2015 : 610931 . 10.1155/2015/610931457573226425124 Search in Google Scholar

22. Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis. Vox Sang 2022;117:1057–69. doi: 10.1111/vox.13296. Shastry S Chenna D Basavarajegowda A Das S Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis . Vox Sang 2022 ; 117 : 1057 – 69 . doi: 10.1111/vox.13296 . 35608911 Open DOISearch in Google Scholar

23. Basu D, Datta SS, Montemayor C, Bhattacharya P, Mukharjee K, Flegel WA. ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India. Transfus Med Hemother 2018;45:62–6. Basu D Datta SS Montemayor C Bhattacharya P Mukharjee K Flegel WA. ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India . Transfus Med Hemother 2018 ; 45 : 62 – 6 . 10.1159/000475507583628329593462 Search in Google Scholar

24. Perkins RP. The significance of the anti-Lewis antibodies in pregnancy. Am J Obstet Gynecol 1970;107:28–32. Perkins RP. The significance of the anti-Lewis antibodies in pregnancy . Am J Obstet Gynecol 1970 ; 107 : 28 – 32 . 10.1016/S0002-9378(16)33886-8 Search in Google Scholar

25. Das S, Shastry S, Rai L, Baliga PB. Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India. Indian J Pathol Microbiol 2020;63:241–6. Das S Shastry S Rai L Baliga PB. Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India . Indian J Pathol Microbiol 2020 ; 63 : 241 – 6 . 10.4103/IJPM.IJPM_737_1932317523 Search in Google Scholar

26. Aggarwal G, Tiwari AK, Arora D, et al. Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018;12:42–5. Aggarwal G Tiwari AK Arora D Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018 ; 12 : 42 – 5 . 10.4103/ajts.AJTS_31_17585069629563674 Search in Google Scholar